See all News/Events

The spring conference season and international acclaim

24th May 2017

We are delighted that we have had yet another strong presence at the leading UK and International Spring conferences in 2017 with our exhibition stands, clinical posters and oral presentations.

The Tissue Viability Society conference in Birmingham at the start of April saw us open the lid on a fascinating debate around patient safety and the classification of powered pressure area care support surfaces. Should these devices be Class I or Class IIa medical devices?

Our stance at Talley is that these devices are an essential part of effective pressure ulcer prevention and management and therefore it is imperative that any manufacturer claims around device performance and safety are independently verified by a notified body before products are assigned a CE mark and sold to customers.

We believe that if devices fail to live up to their performance and safety claims there is a significant risk to both patients and providers and for this reason all powered pressure area care support surfaces need to be Class IIa. 

Raising the bar and classifying this product group as Class IIa devices will help safeguard patients and providers by ensuring that all performance and safety claims around these products are supported with appropriate evidence and data.

No doubt this discussion will continue as we progress throughout the year and towards the autumn conference season.  Rest assured we will provide you with further updates on this topic throughout the year.

On a different note, our International team have enjoyed a particularly busy start to 2017 and as well as participating in a trade mission to South Korea, exhibiting at Arab Health in January and the recent European Wound Management Association conference in Amsterdam earlier this month, they have been collecting several leading SME company awards from the Sunday Times.  These have included listing in the top 100 UK SME companies for fastest-growing exporters and the top 100 for UK SME companies with the fastest growing profit.

These awards are not only testament to the hard work of our International operations team but they are also clear evidence of the continued growth and expansion of Talley at both a national and international level.

Operations Director Kevin Mearns said;

‘We have had an excellent spring conference season both in the UK and at the recent EWMA conference. We continue to have a high profile at these conferences due to our clinical posters and presentations and this is set to continue at the autumn conferences with several clinical abstracts currently being prepared for submission’

‘The recent listings and awards in the various Sunday Times lists clearly point to the fact that as a company we have very clear goals that we working towards and we have a well thought through strategy and a skilled management team in place to enable us to continue our recent growth and expansion.’

‘This is the start of things to come and the next few years are going to be a very exciting time for everyone at Talley’.